Oncolytics Biotech (ONC) Set to Announce Earnings on Thursday

Oncolytics Biotech (TSE:ONC) is set to post its quarterly earnings results after the market closes on Thursday, August 1st. Analysts expect Oncolytics Biotech to post earnings of C($0.10) per share for the quarter.

Oncolytics Biotech (TSE:ONC) last released its earnings results on Thursday, May 9th. The company reported C($0.09) earnings per share for the quarter, topping analysts’ consensus estimates of C($0.12) by C$0.03.

Oncolytics Biotech Price Performance

Oncolytics Biotech stock opened at C$1.41 on Thursday. The business’s 50-day simple moving average is C$1.43 and its 200 day simple moving average is C$1.48. The company has a quick ratio of 8.86, a current ratio of 8.14 and a debt-to-equity ratio of 4.91. The stock has a market cap of C$106.34 million, a price-to-earnings ratio of -3.53 and a beta of 1.49. Oncolytics Biotech has a 12-month low of C$1.20 and a 12-month high of C$4.05.

Analyst Ratings Changes

Separately, Raymond James set a C$3.00 price objective on shares of Oncolytics Biotech and gave the company an “outperform” rating in a report on Thursday, April 4th.

About Oncolytics Biotech

Oncolytics Biotech Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma.